Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19487488

Download in:

View as

General Info

PMID
19487488